Vonoprazan
Vonoprazan is a pharmaceutical drug with 63 clinical trials. Currently 9 active trials ongoing. Historical success rate of 97.5%.
Success Metrics
Based on 39 completed trials
Phase Distribution
Phase Distribution
10
Early Stage
4
Mid Stage
35
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
95.1%
39 of 41 finished
4.9%
2 ended early
9
trials recruiting
63
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
A Study to Evaluate the Efficacy and Safety of Vonoprazan 10 mg Compared to Placebo for Relief of Episodic Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease Through 24 Weeks
Vonoprazan Alone vs With Itopride for Functional Dyspepsia: The VIVA Trial
A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks
Vonoprazan High-Dose Dual VS Levofloxacin Concomitant
Clinical Trials (63)
A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
A Study to Evaluate the Efficacy and Safety of Vonoprazan 10 mg Compared to Placebo for Relief of Episodic Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease Through 24 Weeks
Vonoprazan Alone vs With Itopride for Functional Dyspepsia: The VIVA Trial
A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks
Vonoprazan High-Dose Dual VS Levofloxacin Concomitant
Comparison of Rabeprazole and Vonoprazan in the Prevention of Post-endoscopic Variceal Ligation Ulcer in Patients With Cirrhosis
Comparison of Esomeprazole Versus Vonoprazan in Gastroesophageal Reflux Disease
Vonaprazan Versus Esomeprazole for Healing of LA Grade B or Higher Esophagitis After POEM
Optimization of Minocycline for Helicobacter Pylori Rescue Treatment
PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers
A Randomized, Three-Arm Study Comparing Vonaprazan 10 mg, Vonaprazan 20 mg, and Esomeprazole 40 mg for the Healing of LA Grade B or Higher Reflux Esophagitis at 8 Weeks
Banxiaxiexin Decoction Combined With Vonoprazan-Amoxicillin Dual Therapy in H. Pylori Eradication
Head-to-head Study of Tegoprazan 50 mg BID Plus Amoxicillin 1 g TID vs. Vonoprazan 20 mg BID Plus Amoxicillin 1 g TID for H. Pylori Eradication
Rescue Therapy for Helicobacter Pylori Infection
Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical Trial
Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy
Study on The Efficacy and Safety of Vonoprazan-containing Berberine Triple Therapy in Helicobacter Pylori First-Line Eradication
Special Drug Use Surveillance of Vonoprazan for "Maintenance Therapy of Reflux Esophagitis: Long-term Use"
The Need of Revisiting to an Outpatient Clinic After the Prescription of Vonoprazan or Esomeprazole
The Effects of High-dose Dual Therapy With Probiotics on Gut Microbiota for Helicobacter Pylori Rescue Treatment
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 63